The narrative surrounding off-brand semaglutide and tirzepatide use is beginning to shift as tirzepatide was removed from the FDAs drug shortage list in December and semaglutide was taken off the list in February
GLP-1 RAs, with their high costs, temporary benefits, and serious risks, fall far short of being a reliable solution
Acknowledgments The authors would like to thank SHRM, and particularly SHRM Tennessee and SHRM Austin, as well as the Midwest Business Group on Health, the NC Business Coalition on Health, and The Alliance for their assistance in organizing the focus groups
#AOAC 985.29 Information: Discontinue use and consult your doctor if any adverse reactions occur
Vellura targets the guthormone axis , using herbs that support hormonal balance, gut microbiota diversity, emotional stability, and the control of inflammation not just symptom masking